CERo Therapeutics Holdings, Inc. (CERO)
NASDAQ: CERO · IEX Real-Time Price · USD
1.630
-0.090 (-5.23%)
At close: Mar 27, 2024, 4:00 PM
1.790
+0.160 (9.82%)
Pre-market: Mar 28, 2024, 8:32 AM EDT

CERO Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 20222021
Net Income
-11.83-10.63
Depreciation & Amortization
1.070.74
Share-Based Compensation
0.380.29
Other Operating Activities
-1.33-0.49
Operating Cash Flow
-11.71-10.09
Capital Expenditures
-0.69-0.61
Investing Cash Flow
-0.69-0.61
Share Issuance / Repurchase
0.010.06
Financing Cash Flow
0.010.06
Net Cash Flow
-12.4-10.65
Free Cash Flow
-12.4-10.71
Free Cash Flow Per Share
-1.38-1.19
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).